blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1170281

EP1170281 - 1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.10.2006
Database last updated on 16.07.2024
Most recent event   Tooltip05.10.2007Change - lapse in a contracting state
State(s) deleted from list of lapses: IT
published on 07.11.2007  [2007/45]
Applicant(s)For all designated states
Les Laboratoires Servier
22, rue Garnier
92200 Neuilly sur Seine / FR
[2005/51]
Former [2002/02]For all designated states
LES LABORATOIRES SERVIER
22, rue Garnier
92200 Neuilly sur Seine / FR
Inventor(s)01 / Goldstein, Solo
11, rue du Bac
92150 Suresnes / FR
02 / Guillonneau, Claude
21, rue des Bergéres
92140 Clamart / FR
03 / Charton, Yves
9, allée Esterel
92330 Sceaux / FR
04 / Lockhart, Brian
1/3 rue Maurice Berteaux
78290 Croissy sur Seine / FR
05 / Lestage, Pierre
9, allée de la Grande Terre
78170 La Celle Saint Cloud / FR
 [2002/02]
Application number, filing date01401677.826.06.2001
[2002/02]
Priority number, dateFR2000000820327.06.2000         Original published format: FR 0008203
[2002/02]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP1170281
Date:09.01.2002
Language:FR
[2002/02]
Type: B1 Patent specification 
No.:EP1170281
Date:21.12.2005
Language:FR
[2005/51]
Search report(s)(Supplementary) European search report - dispatched on:EP23.11.2001
ClassificationIPC:C07C219/24, A61K31/21, C07C271/34, C07C217/44, C07C219/18, C07C271/12, C07D213/79, C07D213/65, C07C323/20, A61K31/325, A61K31/435, A61K31/13, C07C217/52, C07D213/70, C07D295/08, A61P25/00
[2002/02]
CPC:
C07D213/70 (EP,US); C07D417/12 (KR); A61P25/00 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/20 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P25/30 (EP); A61P25/34 (EP); A61P29/00 (EP);
A61P29/02 (EP); A61P43/00 (EP); C07C217/44 (EP,US);
C07C217/52 (EP,US); C07C219/18 (EP,US); C07C219/24 (EP,US);
C07C271/12 (EP,US); C07C271/34 (EP,US); C07C323/26 (EP,US);
C07D213/65 (EP,US); C07D295/096 (EP,US); C07C2601/02 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/02]
Extension statesAL20.03.2002
LT20.03.2002
LV20.03.2002
MK20.03.2002
RO20.03.2002
SI20.03.2002
TitleGerman:1,1- and 1,2-Disubstituierte Cyclopropane, Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen[2002/02]
English:1,1- and 1,2-disubstituted cyclopropanes, process for their preparation and pharmaceutical compositions thereof[2002/02]
French:Nouveaux composés cyclopropaniques 1,1 et 1,2-disubstitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent[2002/02]
Examination procedure02.07.2001Examination requested  [2002/02]
25.02.2004Despatch of a communication from the examining division (Time limit: M04)
25.05.2004Reply to a communication from the examining division
15.06.2005Communication of intention to grant the patent
10.10.2005Fee for grant paid
10.10.2005Fee for publishing/printing paid
Opposition(s)22.09.2006No opposition filed within time limit [2006/48]
Fees paidRenewal fee
24.05.2003Renewal fee patent year 03
02.06.2004Renewal fee patent year 04
25.05.2005Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2007/45]
Former [2007/36]IT21.12.2005
Documents cited:Search[A]FR723M  (SMITH KLINE & FRENCH LABS) [A] 1,13-17 * example 5 *;
 [X]EP0066993  (ICI PLC [GB]) [X] 1-3,5,8,9 * example 45 *;
 [A]WO9625160  (NOVO NORDISK AS [DK], et al) [A] 1 * claim - *;
 [X]US6034275  (AEBI JOHANNES [CH], et al) [X] 1-4,8 * column 12, lines 53,54 *;
 [A]  - C. KAISER ET AL., "2-Substituted cyclopropylamines. I. Derivatives and analogs of 2-phenylcyclopropylamine", JOURNAL OF MEDICINAL AND PHARMACEUTICAL CHEMISTRY., AMERICAN CHEMICAL SOCIETY. EASTON., US, (1962), vol. 5, ISSN 0022-2623, pages 1243 - 1265, XP002163312 [A] 1-9,13,14 * page 1246; example 21 * * page 1249; examples 51,56 *

DOI:   http://dx.doi.org/10.1021/jm01241a017
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.